当代医学
噹代醫學
당대의학
CHINA CONTEMPORARY MEDICINE
2014年
10期
87-88
,共2页
李燕军%周良济%郭云洁%王凤永
李燕軍%週良濟%郭雲潔%王鳳永
리연군%주량제%곽운길%왕봉영
血小板减少症%重症监护病房%急性生理学及慢性健康状况评分Ⅱ
血小闆減少癥%重癥鑑護病房%急性生理學及慢性健康狀況評分Ⅱ
혈소판감소증%중증감호병방%급성생이학급만성건강상황평분Ⅱ
Thrombocytopenia%Intensive care unit%Acute physiology and chronic health evaluationⅡ
目的：探讨血小板减少症对重症监护病房（ICU）危重患者预后的判断意义。方法选择2012年1月～2013年3月广东省南雄市人民医院ICU危重患者152例作为研究对象，分析患者入院24 h内急性生理学及慢性健康状况评分Ⅱ（APACHEⅡ）评分与血小板计数的关系，并按照患者的临床预后分为死亡组50例和存活组102例，比较2组的血小板计数。结果 APACHEⅡ评分0～20分的ICU危重患者血小板计数为（86.10±16.43）×109/L，21～40分为（65.58±15.24）×109/L，＞40分为（49.81±12.20）×109/L，ICU危重患者的血小板计数与APACHEⅡ评分显著相关（r=-1.476，P＜0.05），APACHEⅡ评分越高，血小板减少越显著；死亡组血小板计数为（58.21±8.90）×109/L，显著低于存活组的（65.45±10.11）×109/L，差异有统计学意义（t=4.310，P＜0.05）。结论 ICU危重患者静脉血小板计数随着APACHEⅡ评分的增高而减少，是危重病严重程度的监测指标，血小板减少症可以作为判断ICU危重患者预后的临床项目。
目的：探討血小闆減少癥對重癥鑑護病房（ICU）危重患者預後的判斷意義。方法選擇2012年1月～2013年3月廣東省南雄市人民醫院ICU危重患者152例作為研究對象，分析患者入院24 h內急性生理學及慢性健康狀況評分Ⅱ（APACHEⅡ）評分與血小闆計數的關繫，併按照患者的臨床預後分為死亡組50例和存活組102例，比較2組的血小闆計數。結果 APACHEⅡ評分0～20分的ICU危重患者血小闆計數為（86.10±16.43）×109/L，21～40分為（65.58±15.24）×109/L，＞40分為（49.81±12.20）×109/L，ICU危重患者的血小闆計數與APACHEⅡ評分顯著相關（r=-1.476，P＜0.05），APACHEⅡ評分越高，血小闆減少越顯著；死亡組血小闆計數為（58.21±8.90）×109/L，顯著低于存活組的（65.45±10.11）×109/L，差異有統計學意義（t=4.310，P＜0.05）。結論 ICU危重患者靜脈血小闆計數隨著APACHEⅡ評分的增高而減少，是危重病嚴重程度的鑑測指標，血小闆減少癥可以作為判斷ICU危重患者預後的臨床項目。
목적：탐토혈소판감소증대중증감호병방（ICU）위중환자예후적판단의의。방법선택2012년1월～2013년3월광동성남웅시인민의원ICU위중환자152례작위연구대상，분석환자입원24 h내급성생이학급만성건강상황평분Ⅱ（APACHEⅡ）평분여혈소판계수적관계，병안조환자적림상예후분위사망조50례화존활조102례，비교2조적혈소판계수。결과 APACHEⅡ평분0～20분적ICU위중환자혈소판계수위（86.10±16.43）×109/L，21～40분위（65.58±15.24）×109/L，＞40분위（49.81±12.20）×109/L，ICU위중환자적혈소판계수여APACHEⅡ평분현저상관（r=-1.476，P＜0.05），APACHEⅡ평분월고，혈소판감소월현저；사망조혈소판계수위（58.21±8.90）×109/L，현저저우존활조적（65.45±10.11）×109/L，차이유통계학의의（t=4.310，P＜0.05）。결론 ICU위중환자정맥혈소판계수수착APACHEⅡ평분적증고이감소，시위중병엄중정도적감측지표，혈소판감소증가이작위판단ICU위중환자예후적림상항목。
Objective To study the prognosis judgement of thrombocytopenia for critical patients in intensive care unit(ICU).Method From January 2012 to March 2013 in our hospital ICU, 152 cases critical patients were selected as the objects of study, they were concluded within 24 h hospitalized chronic health evaluationⅡ (APACHEⅡ) score and platelet levels relevant information, and they were divided into death group and survival group according with the clinical prognosis, the platelet levels of two groups were compared.Results The platelet levels in patients with APACHEⅡ score 0-20 points was (86.10±16.43)×109/L, 21-40 points was (65.58±15.24)×109/L,>40 points was (49.81±12.20)×109/L, the platelet levels in patients with APACHEⅡ score was signiifcantly correlated (P<0.05), APACHEⅡ score higher the more signiifcant thrombocytopenia; the platelet levels of death group was (58.21±8.90)×109/L, signiifcantly lower than (65.45±10.11)×109/L of the survival group, the difference was statistically signiifcant (P<0.05).Conclusion The platelet levels in critical patients in ICU is increased with the APACHEⅡ score increasing, it is monitoring indicators for the severity of critical illness, and thrombocytopenia is clinical project for the prognosis judgement of thrombocytopenia for critical patients in ICU.
